Protein causes mutations that lead to breast cancer cell aggression

U of A researcher uncovers new mechanism for why a particular biomarker is linked with poor outcomes in certain patients

Protein causes mutations that lead to breast cancer cell aggressionLike most scientists, University of Alberta biochemist Ing Swie Goping is curious. When her team discovered that a protein was associated with poor outcomes in breast cancer patients, she wanted to know why. Now, that curiosity has led to the discovery of a new mechanism for how certain breast cancers develop, which could one day…

Nicotine withdrawal in zebrafish offers clues to human addiction

Study on how fish respond to nicotine exposure suggests researchers could find ways to more effectively treat withdrawal in people with addictions

Nicotine withdrawal in zebrafish offers clues to human addictionResearchers have identified nicotine-induced withdrawal for the first time in the zebrafish model – a discovery that could be used to test ways of treating withdrawal from addiction in humans. Trevor Hamilton, an adjunct professor in the Faculty of Science and member of the Neuroscience and Mental Health Institute at the University of Alberta, examined the role of…

Video series aims to improve cancer screening in North

U of A researchers work with community members to produce culturally appropriate information

Video series aims to improve cancer screening in NorthA series of new videos co-created by University of Alberta researchers and communities in the Northwest Territories are striving to improve the use of cancer screening in the region. The series of 11 videos includes two that offer general information about cancer risks and prevention from a recognized physician in the community. The remaining nine are split…

Simple blood test to predict severity of COVID-19

U of A spinoff company Nanostics using diagnostic technology to help health professionals intervene more quickly

Simple blood test to predict severity of COVID-19A University of Alberta spinoff company focused on creating and commercializing non-invasive diagnostic tests is developing a simple blood test to predict the severity of COVID-19 in positive patients. Nanostics’ test assesses an individual’s viral load, which is the number of viruses they have replicating within their systems, and determines the immune response to COVID-19.…
1 5 6 7